While the Biden administration and US Congress continue to debate ways to address perceived prescription drug pricing concerns, the Food and Drug Administration (FDA) is taking action. Under its Drug ...
Propelled by innovation and scientific collaboration, the Food and Drug Administration’s Office of Generic Drugs Program, or OGD, moved forward in 2021. That is the message Sally Choe, director of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results